143 related articles for article (PubMed ID: 38443586)
1. Thyroid-stimulating hormone levels are associated with estradiol levels and impact reproductive outcomes in preconceptionally euthyroid women undergoing their first IVF/ICSI cycles.
Zhang Y; Li J; Liu Y; Li Z; Guan Y
Hormones (Athens); 2024 Jun; 23(2):269-276. PubMed ID: 38443586
[TBL] [Abstract][Full Text] [Related]
2. Effects of controlled ovarian stimulation on thyroid stimulating hormone in infertile women.
Du YJ; Xin X; Cui N; Jiang L; Yang AM; Hao GM; Gao BL
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():207-212. PubMed ID: 30731333
[TBL] [Abstract][Full Text] [Related]
3. Impact of thyroid-stimulating hormone levels after controlled ovarian hyperstimulation on
Huang N; Chen L; Lian Y; Chi H; Qiao J
Front Endocrinol (Lausanne); 2023; 14():1159991. PubMed ID: 37705573
[TBL] [Abstract][Full Text] [Related]
4. Thyroid function modifications in women undergoing controlled ovarian hyperstimulation for in vitro fertilization: a systematic review and meta-analysis.
Busnelli A; Cirillo F; Levi-Setti PE
Fertil Steril; 2021 Jul; 116(1):218-231. PubMed ID: 33838869
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
Youssef MA; Van der Veen F; Al-Inany HG; Mochtar MH; Griesinger G; Nagi Mohesen M; Aboulfoutouh I; van Wely M
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008046. PubMed ID: 25358904
[TBL] [Abstract][Full Text] [Related]
6. Maternal thyroid function in women undergoing controlled ovarian hyperstimulation during in-vitro fertilization and its relation to reproductive outcome.
Abdul Karim AK; Azrai Abu M; Chelliah B; Mohd Razi ZR; Omar MH; Othman H; Man ZC
Minerva Ginecol; 2017 Oct; 69(5):431-437. PubMed ID: 28447444
[TBL] [Abstract][Full Text] [Related]
7. IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study.
Ye H; Huang GN; Zeng PH; Pei L
J Assist Reprod Genet; 2009 Mar; 26(2-3):105-11. PubMed ID: 19225876
[TBL] [Abstract][Full Text] [Related]
8. The impact of LH, E2, and P level of HCG administration day on outcomes of in vitro fertilization in controlled ovarian hyperstimulation.
Wei M; Zhang XM; Gu FL; Lv F; Ji YR; Liu KF; She H; Hu R
Clin Exp Obstet Gynecol; 2015; 42(3):361-6. PubMed ID: 26152012
[TBL] [Abstract][Full Text] [Related]
9. Analysis of in vitro fertilization/intracytoplasmic sperm injection outcomes in infertile women with a history of thyroid cancer: a retrospective study.
Huang N; Zeng L; Yan J; Chi H; Qiao J
Reprod Biol Endocrinol; 2021 Jun; 19(1):82. PubMed ID: 34088310
[TBL] [Abstract][Full Text] [Related]
10. TSH levels after fresh embryo transfer are associated with reproductive outcomes in euthyroid women undergoing the first IVF/ICSI cycles.
Zhang Y; Liu Y; Wu W; Li Z; Ren B; Guan Y
Sci Rep; 2023 Jun; 13(1):8963. PubMed ID: 37268813
[TBL] [Abstract][Full Text] [Related]
11. Effect of antithyroid antibodies on ICSI outcome in antiphospholipid antibody-negative euthyroid women.
Karacan M; Alwaeely F; Cebi Z; Berberoglugil M; Batukan M; Ulug M; Arvas A; Camlıbel T
Reprod Biomed Online; 2013 Oct; 27(4):376-80. PubMed ID: 23953066
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).
Kwan I; Bhattacharya S; Woolner A
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD005289. PubMed ID: 33844275
[TBL] [Abstract][Full Text] [Related]
13. Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles.
Zhou C; Yang X; Wang Y; Xi J; Pan H; Wang M; Zhou Y; Xiao Y
Hum Reprod; 2022 Jul; 37(8):1795-1805. PubMed ID: 35595223
[TBL] [Abstract][Full Text] [Related]
14. Reproductive outcomes of dual trigger with combination GnRH agonist and hCG versus trigger with hCG alone in women undergoing IVF/ICSI cycles: a retrospective cohort study with propensity score matching.
Dong L; Lian F; Wu H; Xiang S; Li Y; Wei C; Yu X; Xin X
BMC Pregnancy Childbirth; 2022 Jul; 22(1):583. PubMed ID: 35869444
[TBL] [Abstract][Full Text] [Related]
15. Incidence of elevation of serum thyroid-stimulating hormone during controlled ovarian hyperstimulation for in vitro fertilization.
Benaglia L; Busnelli A; Somigliana E; Leonardi M; Vannucchi G; De Leo S; Fugazzola L; Ragni G; Fedele L
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():53-7. PubMed ID: 24332278
[TBL] [Abstract][Full Text] [Related]
16. LH on GnRH-ant day to basal LH affects the IVF/ICSI outcome of PCOS women undergoing GnRH-antagonist protocol.
Wei Y; Luan T; Shen J; Zhang J; Zhang J; Su Y; Ling X; Li X; Zhao C
Int J Gynaecol Obstet; 2024 Feb; 164(2):624-632. PubMed ID: 37724009
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).
Kwan I; Bhattacharya S; Kang A; Woolner A
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD005289. PubMed ID: 25150465
[TBL] [Abstract][Full Text] [Related]
18. Association between TSH Level and Pregnancy Outcomes in Euthyroid Women Undergoing IVF/ICSI: A Retrospective Study and Meta-analysis.
Jin L; Wang M; Yue J; Zhu GJ; Zhang B
Curr Med Sci; 2019 Aug; 39(4):631-637. PubMed ID: 31347001
[TBL] [Abstract][Full Text] [Related]
19. Impaired outcome of controlled ovarian hyperstimulation in women with thyroid autoimmune disease.
Magri F; Capelli V; Gaiti M; Brambilla E; Montesion L; Rotondi M; Spinillo A; Nappi RE; Chiovato L
Thyroid; 2013 Oct; 23(10):1312-8. PubMed ID: 23556516
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol.
Scheffer JB; Scheffer BB; Carvalho RF; Aguiar AP; Lozano DHM; Labrosse J; Grynberg M
JBRA Assist Reprod; 2019 Aug; 23(3):239-245. PubMed ID: 30875186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
